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http://dx.doi.org/10.1016/j.bgm.201Abstract This study aimed to evaluate the antidiabetic activity of Strychnos potatorum
seeds in streptozotocin-nicotinamideeinduced diabetes in experimental animals. Noninsulin-
dependent diabetes mellitus (NIDDM) was induced in overnight fasted rats by an intraperito-
neal injection (i.p.) of 60 mg/kg streptozotocin (STZ) and, after a 15-minute interval,
120 mg/kg of nicotinamide. S. potatorum extract 200 mg/kg or 400 mg/kg body weight was
administered orally to the rats once daily for 21 days. The blood glucose level was assessed
by a glucometer. The serum levels of cholesterol, triglycerides, and total lipid were deter-
mined by using diagnostic kits. Measurement of catalase (CAT), superoxide dismutase (SOD),
glutathioneeS-transferase (GST), reduced glutathione (GSH), and glutathione peroxidase
(GPx) were determined to ascertain the antioxidant activity. A significant reduction in the
blood glucose level was observed in diabetic animals treated with the different doses of the
extract, compared to untreated diabetic rats. The treatment with the extract significantly
increased the levels of GSH, GPx, GST, CAT, and SOD in the drug-treated group to levels com-
parable to the levels in the diabetic control group. The result of this study thus shows that 50%of Pharmacognosy, United Institute of Pharmacy, Allahabad 211010, India.
mail.com (S.B. Mishra).
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158 S.B. Mishra et al.of the ethanolic extract at different doses possesses significant antidiabetic activity and
potent antioxidant potential in diabetic conditions.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
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In developing countries, the most common form of dia-
betes is noninsulin-dependent diabetes mellitus (NIDDM).
The disorder affects more than 100 million people world-
wide and by 2030 it is predicted that it will affect 366
million people.1 There are several differences in the
clinical presentation of NIDDM in tropical countries. Pe-
ripheral insulin resistance is a key feature of NIDDM and
results from a combination of sedentary lifestyle, un-
healthy dietary habits, and genetic predisposition.2 Insulin
resistance is also implicated in several life-threatening
disorders, collectively referred to as the metabolic
syndrome.3
Apart from currently available therapeutic options,
many herbal medicines have been recommended for the
treatment of diabetes. Traditional plant medicines are used
throughout the world for a range of diabetic presentations.
Herbal drugs are prescribed widely because of their effec-
tiveness, fewer side effects, and relatively low cost.4 India
has a rich history of using various potent herbs and herbal
components for treating diabetes. Many Indian plants have
been investigated for their beneficial use in treating
different types of diabetes and have been reported in
numerous scientific journals. Strychnos potatorum is a
native plant of India and plentiful in the deciduous forests
of West Bengal, Central India, and in South India up to 1200
meters. The ripe seeds are used for clearing muddy water.
The clarification occurs because of the combined actions of
colloids and alkaloids in the seeds. The seeds reportedly
possess diuretic activity5; antidiarrheal activity6; hep-
atoprotective and antioxidant activity7; antiulcer and anti-
inflammatory activity8,9; and antiarthritic activity.10 In
Madras, India the seeds are traditionally used in treating
diabetes and gonorrhea.11 A new triterpenoid, isomotiol,
and alkaloids have been isolated from the bark of the
plant.12 The objective of this investigation was to ascertain
the scientific basis for the antidiabetic potential of S.
potatorum in streptozotocin-nicotinamide-induced dia-
betic rats.Materials and methods
Plant material
Candidate plant material was collected from the local
herbal drug market. The plant materials were authenti-
cated by taxonomist Dr. A.K.S. Rawat, PhD. For future
reference, the voucher specimen (CIF-RB-2-126-2) has been
deposited in the departmental herbarium of the National
Botanical Research Institute in Lucknow, India.Preparation of the S. potatorum extract
The S. potatorum seeds (1 kg) were air-dried and then
powdered. The powder was prepared by grinding the dried
seeds in a blender. Five hundred grams of the seed powder
was macerated with petroleum ether to remove fatty sub-
stances; the marc was further exhaustively extracted with
50% ethanol for 3 days (3  3 L) by using the cold perco-
lation method and by centrifugation at 10,000 revolutions
per minute (rpm). The extract was separated by filtration
and concentrated on rotavapour (Buchi, New Castle, DE,
USA), and then dried in lyophilizer (Heto Drywinner;
Thermo Scientific, LLC, USA) under reduced pressure. This
yielded 215.0 g of solid residue (i.e., a yield of 21.5% w/w).
Phytochemical screening
Phytochemical screening of the ethanolic extract was per-
formed by standard procedures that revealed the presence
of chemical constituents such as carbohydrates, phytos-
terols, alkaloids, flavonoids, and saponins.13
Experimental animals
Healthy adult Wistar albino rats of both sexes were used for
the pharmacological studies. They were 2e3 months of age
and weighed 200e250 g. The animals were housed in poly-
propylene cages, maintained under standard conditions of
12/12 hours of light/dark at 25C  3C and 35e60% hu-
midity. They were fed with a standard rat pellet diet (Amrut,
India) and water ad libitum. The Institutional Animal Ethical
Committee of the United Institute of Pharmacy (Allahabad,
India; No. 1451/PO/a/11/CPCSEA) approved the study.
Oral acute toxicity study
The lethal median dose (LD50) determination was per-
formed in mice by Organisation for Economic Co-operation
and Development (OECD) Guideline 423.14 A single dose of
the extracts (i.e., 5 mg/kg, 50 mg/kg, 300 mg/kg, or
2000 mg/kg) in the appropriate quantity of water was
administered orally by gavage to different groups of mice
(three mice in each group). The animals were allowed free
access to water and food. However, all the animals were
deprived of food for 2 hours prior to dosing and 4 hours
after dosing. For the first 12 hours, the animals were
initially monitored continuously for any adverse effects for
4 hours and then monitored at 1-hour intervals. They were
later monitored twice daily for any abnormal changes
throughout the study period (which lasted 14 days). The
lethal median dose (LD50) of the 50% ethanolic extract of
the S. potatorum seeds was 2000 mg/kg. One-tenth of the
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selected for pharmacological activity (i.e., 200 mg/kg and
its double strength of 400 mg/kg of body weight [b.w.]).15
Experimental induction of diabetes
Streptozotocin (STZ) was freshly dissolved in citrate buffer
(0.1 M at pH 4.5) and nicotinamide was dissolved in normal
physiological saline and maintained on ice prior to use. All
animals were allowed to adapt to their cages for 3 days,
after which they were fasted overnight. Noninsulin-
dependent diabetes mellitus was induced in the
overnight-fasted rats by a single intraperitoneal injection
of STZ (60 mg/kg b.w.). Fifteen minutes after the intra-
peritoneal administration of nicotinamide (120 mg/kg
b.w.), all animals were allowed free access to food and
water. Their blood glucose levels were measured 2 days
after the STZ injection and were used as parameters to
obtain matching pairs of rats with diabetes at a similar level
of severity. Only rats with fasting blood glucose levels
greater than 220 mg/dL were considered to be diabetic and
were used in the experiment. The animals were randomly
assigned to five different groups (i.e., Group IeGroup V).
Group I served as the control and contained six normal rats.
All treatments started 3 days after the STZ injection.16
Experimental design
Five groups of rats were used to study the effect of 50%
ethanolic extract of S. potatorum. Each group consisted of
six rats and were as follows.
Group I. The control rats, which received vehicle normal
saline solution.
Group II. Diabetic control rats, which received the
vehicle normal saline solution.
Group III. Diabetic rats, which were treated with extract
200 mg/kg body weight.
Group IV. Diabetic rats, which were treated with extract
at 400 mg/kg body weight.
Group V. Diabetic rats, which were treated with the
standard drug glibenclamide at 600 mg/kg body weight.
The vehicles and the drugs were administered orally for
three weeks by using an oral gavage tube daily. To measure
the blood glucose level, blood samples were collected from
the tail vein on Day 0, Day 7, Day 14, and Day 21. The blood
glucose level was determined by a glucometer (SugarScan;
Thyrocare Technologies Limited, Navi Mumbai, India). The
values of the treated groups were compared to the values
of the standard group that was treated with glibenclamide.
The animals were then sacrificed by cervical dislocation.
The liver, kidney, and pancreas were exposed and perfused
with cold saline phosphate buffer (at pH 7.4) for histo-
pathological examination. The blood-free liver and kidney
were removed and separately homogenized in a glass
Teflon homogenizer; Thomas Scientific, NJ, USA (10% w/v).
Incubation was performed at 37C under controlled condi-
tions for biochemical estimation. The collected blood
samples were immediately centrifuged at 2500 rpm for 15
minutes. The separated serum was collected in fresh serumtubes, which were tightly capped and then stored in a
refrigerator (2e4C). The effect of the test extracts on the
levels of serum glucose, antioxidant enzymes, and lipid
profile were assessed.In vivo antioxidant activity in diabetic rats
Measurement of superoxide dismutase activity
Superoxide dismutase (SOD) was estimated, based on the
method of Pari.17 In this mixture, 2.5 mL of ethanol and
1.5 mL of chloroform (all reagents were chilled) were
added and shaken for 1 minute at 4C, and then centri-
fuged. The enzyme activity in the supernatant was deter-
mined. The assay mixture contained 1.2 mL of sodium
pyrophosphate buffer (0.025 M, pH 8.3), 0.1 mL of 186 mM
phenazine methosulfate (PMS), 0.3 mL of 30 mM nitroblue
tetrazolium (NBT), 0.2 mL of 780 mM nicotinamide adenine
dinucleotide (NADH); an appropriately diluted enzyme
preparation; and water in a total volume of 3 mL. The re-
action was initiated by the addition of NADH. The mixture
was further incubated for 120 seconds at 37C in a water
bath. The reaction was stopped by adding 1 mL glacial
acetic acid (17.4 M). A violet color developed. The solution
was extracted in 4.0 mL of an n-butanol reagent blank. The
activity was measured at 560 nm and the results are
expressed as units (U) of SOD activity/mg protein. One unit
of enzyme activity was defined as the enzyme concentra-
tion required to inhibit the chromogen production by 50% in
1 minute under the defined assay conditions.
Measurement of catalase activity
Decomposition of hydrogen peroxide (H2O2) in the presence
of catalase was followed at 240 nm.17 A 50 mM sample was
added to buffered substrate (50 mM phosphate buffer, pH
7.0 containing 10 mM H2O2) to make a total volume of 3 mL,
and the decrease in the absorbance was monitored at 37C
for 2.5 minutes at 15-second intervals. The activity was
calculated by using the extinction coefficient of H2O2 of
0.041/(mmolecm2) at 240 nm. Results are expressed as
units (U) of catalase (CAT) activity/mg protein.
Determination of glutathione-S-transferase
The enzyme glutathione-S-transferase (GST) was measured
in accordance with the Pari method.17 Liver homogenate
(0.1 mL), buffer (1.0 mL), double distilled water (1.7 mL),
and chloro-dinitro benzene (CDNB) reagent (0.1 mL) were
mixed. The mixture was incubated at 37C for 15 minutes,
and then 0.1 mL of GSH was added. The change in optical
density was read at 340 nm from 0 minutes to 3.0 minutes in
a Shimadzu UV-visible spectrophotometer; SHIMADZU
CORPORATION, Kyoto, Japan. The activity of GST was
expressed as mg/mg of protein.
Determination of reduced glutathione
The liver and kidney homogenates were mixed with 0.5 mL
of 5% trichloroacetic acid (TCA) in 0.1 mM EDTA. Each sample
was centrifuged at 2000 rpm for 10 minutes. The superna-
tant was then mixed with 2.5 mL of 0.1 M phosphate buffer
(at pH 8). The color was developed by adding 100 mL of 0.01%
5,50-dithiobis-(2-nitrobenzoic acid) (DTNB). The absorbance
was measured at 412 nm by a spectrophotometer.17
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A 0.2-mL sample each of 0.8 mM EDTA, 10 mM sodium azide,
reduced glutathione, and H2O2; 0.4 mL of phosphate buffer;
and 0.1 mL of enzyme (i.e., liver and kidney homogenates)
were mixed and incubated at 37C for 10 minutes. The
reaction was arrested by adding 0.5 mL of 10% TCA. The
tubes were centrifuged. Three milliliters of sodium
hydrogen phosphate and 1.0 mL of DTNB were added to
0.5 mL of the supernatant. The color developed and was
read at 412 nm immediately in a UV-visible spectropho-
tometer. Graded concentrations of the standard were
similarly treated. Glutathione peroxidase activity in the
liver homogenate is expressed as millimoles per milligram
(mmol/mg) of tissue.17Histopathology
At the end of the treatment period, the control and treated
rats were sacrificed by cervical dislocation. Their pancreas
was dissected. Part of the pancreatic tissue was immedi-
ately fixed in Bouin’s fluid for 24 hours. The tissues was
then washed in running tap water to remove the color of
Bouin’s fluid, and then dehydrated in alcohol in ascending
and descending order. They were embedded in paraffin and
cut at 5 mm sections in a rotary microtome. These sections
were then deparaffinized in xylene, stained with
hematoxylin-eosin, and mounted with Canada balsam. The
histopathological slides were examined and photographs
were captured with a digital stereomicroscope (Olympus,
B061, USA).18Statistical analysis
All statistical pharmacological analyses were performed by
using GraphPad Prim version 3.03 software for Windows,
GraphPad Software, Inc. La Jolla, CA, USA. The values are
presented as the mean  the standard deviation (SD). The
data of six rats were analyzed by the Student t test and the
analysis of variance (ANOVA) with pos hoc difference was
analyzed by using the Newman-Keuls method.Table 1 The effect of 50% ethanolic extract of Strychnos potat
diabetic rats.
Group Treatment (dose) 0 day (mg/dL) Afte
(mg
I Normal control 78.45  12.41 76
II Diabetic control 248.22  32.56*** 227
III Extract (200 mg/kg) 238.36  2.64 209
IV Extract (400 mg/kg) 256.43  2.25 162
V Glibenclamide
(600 mg/kg)
233.56  13.40 186
The data represents the mean  standard deviation for six rats per g
* Indicates statistical significance, compared to the diabetic control
** Indicates statistical significance, compared to the diabetic control
*** Indicates statistical significance, compared to the normal group (p
STZ Z streptozotocin.Results
Antihyperglycemic activity
Table 1 shows the effect of the oral daily administration of
50% ethanolic extract (200 mg/kg and 400 mg/kg) on the
blood glucose level in 21 days. By the end of treatment, the
blood glucose level reduced from 238.36 mg/dL to
132.28 mg/dL in rats treated at a dose of 200 mg/kg
(p < 0.001). For the oral administration of 400 mg/kg of the
extract, the blood glucose level reduced from 256.43 mg/dL
to 118.24 mg/dL at 21 days (p < 0.001). For glibenclamide
(600 mg/kg), the blood glucose level reduced from
233.56 mg/dL to 94.68 mg/dL (p< 0.001). Table 2 shows the
levels of biochemical parameters such as the levels of total
cholesterol, triglycerides, and total lipids. In the STZ-
nicotinamide-treated group, the cholesterol level was
72.83mg/dL in the normal control group and 153.66mg/dL in
the diabetic control group (p < 0.001), and the triglyceride
level was 70.16 mg/dL in the normal control group and
115.66 mg/dL in the diabetic control group (p < 0.001). By
contrast, the 50% ethanolic extract of S. potatorum seeds in
the groups treated at a dose of 200 mg/kg or 400 mg/kg once
daily for 21 days prevented the diabetic condition in a dose-
related manner. The results were moderately significant.
In vivo antioxidant activity
Table 3 presents the enzyme activities. Significant reductions
in GSH, GPx, GST, SOD, and catalase were observed in the
diabetic control rats in comparison to the normal control rats.
There was a significant increase in GST, GPx, and CAT in
the kidney and in the liver [GST, 6.59  0.29 mmol CDNB-
GSH conjugate/(minmg1 protein); GPx, 9.17  0.88 mg
glutathione consumed/(minmg1 protein); CAT,
70.22  1.24 mmol of H2O2 consumed/(minmg1 protein)].
There was a significant increase in the liver GSH level (to
128.67  2.54 nM of conjugated DTNB/mg protein), whereas
there was no significant increase in the kidney GSH on the
administration of the 400 mg/kg dose. The SOD level
(6.22  0.43 U min/mg Hb) in erythrocytes decreased on theorum on the serum glucose level in STZ-nicotinamide-induced
r 7 days
/dL)
After 14 days
(mg/dL)
After 21 days
(mg/dL)
.12  11.80 77.46  10.32 78.86  9.36
.24  36.14*** 229.46  32.12*** 212.32  26.12***
.36  3.46 168.46  3.26* 132.28  3.14**
.46  2.17 124.32  2.43** 118.24  1.22**
.06  12.76 134.51  8.21** 94.68  5.37**
roup.
group (p < 0.05).
group (p < 0.001).
< 0.001).
Table 2 The effect of 50% ethanolic extract of Strychnos potatorum on the total cholesterol, triglyceride, and lipid levels in
the blood serum after 21 days.
Groups Treatment (dose) Triglyceride (mg/dL) Total cholesterol (mg/dL) Total lipids (mg/dL)
I Normal control 70.16  4.81 72.83  4.74 84.83  5.14
II Diabetic control 115.66  3.94**** 153.66  5.24**** 148.83  4.29****
III Extract (200 mg/kg) 108.12  2.65 104.47  1.36*** 134.36  1.18*
IV Extract (400 mg/kg) 88.19  1.26*** 78.65  1.98*** 126.54  2.48**
V Glibenclamide
(600 mg/kg)
75.66  4.92*** 81.83  7.77*** 93.33  5.73***
The data represents the mean  standard deviation for six rats per group.
* Indicates statistical significance, compared to the diabetic control group (p < 0.05).
** Indicates statistical significance, compared to the diabetic control group (p < 0.01).
*** Indicates statistical significance, compared to the diabetic control group (p < 0.001).
**** Indicates statistical significance, compared to the normal group (p < 0.001).
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ment with 50% ethanolic extract, thereby restoring the SOD
level to nearly that of the normal control group. The results
were comparable to that of glibenclamide. The activities of
these enzymes decreased significantly in the diabetic control
rats in comparison to the normal control rats. The oral
administrationof the extract (at 200mg/kg or 400mg/kg body
weight) for 3 weeks significantly reversed these enzymes to
near-normal values.
Histopathological studies
Microscopically examined pancreas section of the control
group showed normal islets, the architecture wasTable 3 The effect of Strychnos potatorum extract on antioxida
Parameters GSH (nM of DTNB
conjugated/
mg protein)
GST [mmol of CDNB-GSH
conjugate formed/
minmg1 protein)]
GPx [m
consum
(minm
Normal control
Liver 129.67  2.66 6.75  0.97 9.38 
Kidney 118.77  2.31 6.88  0.34 7.33 
Diabetic control
Liver 74.23  1.51***** 3.42  0.18***** 5.19 
Kidney 46.17  2.49***** 2.66  0.27 4.99 
Extract-treated (200 mg/kg)
Liver 107.97  1.97* 4.55  0.63** 6.11 
Kidney 71.22  3.14 (NS) 3.69  0.71* 5.22 
Extract-treated (400 mg/kg)
Liver 128.67  2.54*** 6.59  0.29*** 9.17 
Kidney 91.33  2.89 (NS) 5.11  0.33** 6.97 
Glibenclamide-treated (600 mg/kg)
Liver 130.56  1.41*** 5.12  0.11** 7.24 
Kidney 95.17  2.55 (NS) 3.76  0.91** 5.66 
The data represents the mean  standard deviation for six rats per g
* Indicates statistical significance, compared to the diabetic control g
** Indicates statistical significance, compared to the diabetic control
*** Indicates statistical significance, compared to the diabetic contro
**** Indicates statistical significance, compared to the normal group (
***** Indicates statistical significance, compared to the normal group
CAT Z catalase; CDNB Z chloro-dinitro benzene; DTNB Z 5,5’-d
GSH Z glutathione; GST Z glutathione-S-transferase; H2O2 Z hydro
STZ Z streptozotocin; U Z units.preserved, and the acini were lined by round to oval cells
with moderate cytoplasm and small round to oval nuclei
(Fig. 1A). However, in the diabetic control group, the islets
showed depleted cells, the architecture was preserved, and
the acini were lined by round to oval cells with moderate
cytoplasm and small round to oval nuclei (Fig. 1B). In the
200 mg/kg extract-treated group, the architecture was
partially effaced, the islets were normal, and there was a
mild and diffuse infiltrate of lymphocytes within the stroma
(Fig. 1C). In the 400 mg/kg extract-treated group, the ar-
chitecture was normal, the islets showed depletion of the
acinar cells, and there was no evidence of inflammation
(Fig. 1D); however, in the standard-treated group, there
was a mild infiltrate of lymphocytes at some foci and thent enzyme activity in STZ-nicotinamide-induced diabetic rats.
g glutathione
ed/
g1 protein)]
CAT [mmol of H2O2
consumed/
(minmg1 protein)]
SOD [U min/(mgHb1)]
in erythrocytes
0.91 71.25  2.17 6.34  0.19
0.14 38.33  1.22
0.88***** 38.67  1.92***** 3.41  0.22*****
1.01**** 20.55  1.75****
0.74** 56.41  3.69** 4.97  0.62**
0.44* 25.69  1.20*
0.88*** 70.22  1.24*** 6.22  0.43***
0.76*** 36.57  1.41***
0.61** 65.31  2.56*** 5.18  0.31**
0.58* 35.24  1.81***
roup.
roup (p < 0.05).
group (p < 0.01).
l group (p < 0.001).
p < 0.01).
(p < 0.001).
ithiobis-(2-nitrobenzoic acid); GPx Z glutathione peroxidase;
gen peroxide; Hb Z hemoglobin; SOD Z superoxide dismutase;
Figure 1 Pathologic findings. (A) The islets of Langerhans are normal and the architecture is preserved. (B) The islets show the
depletion of cells. (C) The islets are normal but have a mild and diffuse infiltrate of lymphocytes within the stroma. (D) The islets
show depletion of the acinar cells, but there is no evidence of inflammation. (E) Some foci show mild infiltration of lymphocytes.
The acini are lined by round to oval cells with moderate cytoplasm and small round to oval nuclei. (Hematoxylin and eosin stain;
original magnification, 200.)
162 S.B. Mishra et al.acini were lined by round to oval cells with moderate
cytoplasm and small round to oval nuclei (Fig. 1E).Discussion
There are numerous pathways and mechanisms involved in
the manifestation of diabetes, which cannot be signifi-
cantly cured by a single drug or by a drug acting on a single
target or receptor. The medicinal preparations in conven-
tional medicines contain a variety of herbal and nonherbal
constituents that act on an array of targets by various
modes and mechanisms. The STZ-nicotinamide injection
caused diabetes mellitus, which may have resulted from
the destruction of beta cells of the islets of Langerhans of
the pancreasdfollowed by insulin deficiencydand may
have led to a variety of derangements in metabolic and
regulatory processes.19 Our investigations indicate the ef-
ficiency of the extract in maintaining blood glucose levels inSTZ-nicotinamide-induced diabetic rats. The administra-
tion of an aqueous ethanolic extract of S. potatorum to
diabetic rats moderately decreased the blood glucose
levels. A possible mechanism by which the 50% ethanolic
extract exerts its hypoglycemic action in diabetic rats may
be by potentiating the plasma insulin effect either by
increasing the pancreatic secretion of insulin from the
existing beta cells or by increasing the release of insulin
from its bound form. A marked increase in the level of total
cholesterol has been observed in untreated diabetic rats.
Under normal circumstances, insulin activates the enzyme
lipoprotein lipase and hydrolyses triglycerides. Insulin
deficiency results in failure to activate the enzyme,
thereby causing hypertriglyceridemia. The significant con-
trol of the levels of serum lipids in the extract-treated
diabetic rats may be directly attributed to improvements
in insulin levels with extract therapy. The induction of
diabetes with STZ is associated with the characteristic loss
of body weight, which results from increased muscle
Preclinical evaluation of antihyperglycemic and antioxidant action 163wasting and loss of tissue proteins.20 The treatment of
prediabetic animals with nicotinamide improves diabetic
metabolic alteration, most likely by counteracting beta cell
dysfunction and loss associated with oxidative stress.21,22
However the exact mechanism of the action of nicotin-
amide in diabetes remains under investigation.
One consequence of hyperglycemia is increased meta-
bolism of glucose by the sorbitol pathway. Besides this, other
pathways, such as fatty acid and cholesterol biosynthesis
also compete for NADPHwith GSH. The decrease in GSH level
in the liver during diabetes is probably because of its
increased utilization by the hepatic cells which could be the
result of decreased synthesis or increased degradation of
GSH by oxidative stress in diabetes.23 We have also observed
a decrease inGSH in the liver and the kidney. The activities of
GPx and GST decreased significantly in diabetic rats. GPx (a
selenium-containing enzyme) and GST catalyze the reduc-
tion of hydrogen peroxide to nontoxic compounds.
The administration of the extract or glibenclamide
increased the activity of GPx and GST in diabetic condi-
tions. The enzymers enzymes SOD and catalase are two
major scavenging enzymes that remove the toxic-free
radical in vivo. Reduced SOD activity in erythrocytes and
reduced catalase activity in the liver and kidney have been
observed during diabetes, and this may result in several
deleterious effects because of the accumulation of super-
oxide radicals and H2O2.
24
In conclusion, the results presented in this study suggest
the following: (1) S. potatorum possesses antidiabetic and
antioxidant activity; (2) one or more antidiabetic com-
pounds in the plant extract improve the physiology of rats
affected by type 2 diabetes; and (3) bioactive constituents
responsible for improving the physiology of type 2 diabetic
rats need to be isolated and characterized to contribute to
better treatment of NIDDM.Acknowledgments
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